Global Cell Imagers Market 2017-2021


Report ID : RNR-90883 Category : Biotechnology Published Date : June 2017
Publisher : Technavio Pages : 86 Format : PDF
The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales forecasts by country and market segment, including:

- Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs 

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country. Also, the report:

- Examines market applications of Molecular Diagnostics,Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; 

- Reviews features and operating characteristics of major analyzers usedfor STD testing; 

- Profiles key suppliers and potential market entrants developing innovativetechnologies and products; and 

- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan. 

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.
About Cell Imagers

Cell imaging is the study of examining cell structures through various devices such as microscopes to better understand cellular mechanisms to help diagnose diseases and discover drugs. There are several methods of cell imaging, which include fluorescence microscopy (FM), high content screening (HCS), in situ hybridization (ISH), confocal laser scanning microscopy (CLSM), immunofluorescence imaging (IFI), super-resolution microscopy (SRM), and automated imaging. Some critical factors such as the maintenance of healthy cells at the microscope stage and the establishment of a feasible environment that is ideal for cells and does not affect their functionalities need to be ensured during cell imaging.

Technavio’s analysts forecast the global cell imagers market to grow at a CAGR of 8.21% during the period 2017-2021.

Covered in this report 

The report covers the present scenario and the growth prospects of the global cell imagers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales cell imagers.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Cell Imagers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors
ZEISS International
Leica Microsystems
GE Healthcare
Thermo Fisher Scientific
Other prominent vendors
ATTO Corporation
Biological Industries
BioTek Instruments
Bio-Rad Laboratories
Becton Dickinson (BD)
Essen Bioscience
Enzo Life Sciences
Nikon Corporation
Olympus Corporation
PerkinElmer
Market driver
Growing prevalence of chronic diseases
For a full, detailed list, view our report
Market challenge
Technical and economic challenges of super resolution
For a full, detailed list, view our report
Market trend
Extensive use of automation in live cell imaging
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Press Release

Technavio Announces the Publication of its Research Report – Global Cell Imagers Market 2017-2021

Technavio recognizes the following companies as the key players in the global cell imagers market: ZEISS International, Leica Microsystems, GE Healthcare, and Thermo Fisher Scientific. 

Other Prominent Vendors in the market are: ATTO Corporation, Biological Industries, BioTek Instruments, Bio-Rad Laboratories, Becton Dickinson (BD), Essen Bioscience, Enzo Life Sciences, Nikon Corporation, Olympus Corporation, and PerkinElmer. 

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is extensive use of automation in live cell imaging. Cell imaging is an important tool for the efficient study of cell biology and discovery of drugs. Hence, the automation of cell imaging can reduce the time spent by researchers on tasks such as sample loading, which allows them to spend time on analyzing and interpreting the results obtained from cell imaging. Automated microscopy solutions are offered by most vendors and are being increasingly deployed in various diagnostic centers and research laboratories. These solutions increase the overall lab output as they assist in analyzing more samples.”

According to the report, one of the major drivers for this market is growing prevalence of chronic diseases. Globally, chronic diseases such as cancer, diabetes, arthritis, heart diseases, and stroke are the leading causes of deaths. The prevalence of these diseases is increasing at alarming rates. The CDC estimates that by 2020, the number of new cancer cases is expected to increase by nearly 2 million each year.

Further, the report states that one of the major factors hindering the growth of this market is technical and economic challenges of super resolution. To achieve better results and generate more insights about cellular processes, there has been an immense need to develop imaging equipment that provide better resolution. However, the various approaches used to achieve this have been ineffective to solve real-world problems. Issues related to resolution have been the most common cited challenge among key opinion leaders at various annual conferences held to discuss advancements and issues related to microscopy.



Companies Mentioned

ZEISS International, Leica Microsystems, GE Healthcare, Thermo Fisher Scientific, ATTO Corporation, Biological Industries, BioTek Instruments, Bio-Rad Laboratories, Becton Dickinson (BD), Essen Bioscience, Enzo Life Sciences, Nikon Corporation, Olympus Corporation, and PerkinElmer.